IBD Connected with Increased Risk of Pneumonia

Published Online: Thursday, February 14, 2013
Follow Pharmacy_Times:
Patients with inflammatory bowel disease (IBD) may be at a higher risk for pneumonia, according to a study published online on January 8, 2013, by The American Journal of Gastroenterology.

Researchers compared patients with IBD with 4 matched controls from the LifeLink Health Plan Claims Database. The study included more than 50,000 patients with Crohn’s disease and more than 55,000 patients with ulcerative colitis. Researchers also analyzed possible associations between medications and pneumonia risk.

The study authors found that patients with IBD had an increased risk of pneumonia when compared with patients without IBD. Both Crohn’s disease patients and ulcerative colitis patients were at a higher risk for pneumonia. The researchers also found that use of biologic medications, corticosteroids, thiopurines, proton pump inhibitors, and narcotics were all connected to an increased risk in pneumonia.

The researchers suggest that patients with IBD can attempt to reduce their risk of pneumonia through vaccination, which should occur at diagnosis with IBD if possible. Other risk factors, such as use of corticosteroids and narcotics, can be addressed and minimized by prescribing alternative therapies when appropriate.

Related Articles
Teva Pharmaceutical Industries recently launched generic versions of Sanofi’s enoxaparin sodium injection (Lovenox) and Pfizer’s linezolid injection (Zyvox).
Patients, especially infants, who are infected with respiratory syncytial virus may face an increased risk of developing pneumonia caused by Streptococcus pneumoniae, a recent study suggests.
Narcotics are not recommended for managing chronic pain in children with inflammatory bowel disease, due to gastrointestinal side effects and potential dependence. Nevertheless, researchers have uncovered that long-term narcotic use is more than twice as prevalent in pediatric IBD patients compared with the general population.
As the US Centers for Disease Control and Prevention continues to report more measles infections, the University of California is taking a strong stance on immunization.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$